KABIR KASHIF HUSAIN

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SHREVEPORT, LA NPI 1306308176

General Payments — all program years on this page

$943.74

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $578.08 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $578.0819

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $20.681
2022 $136.425
2023 $208.5611
2024 $578.0819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078682308 Janssen Biotech, Inc. $17.27 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078682447 Janssen Biotech, Inc. $14.68 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078684406 Janssen Biotech, Inc. $21.04 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103957902 ABBVIE INC. $20.82 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103957904 ABBVIE INC. $22.34 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103957906 ABBVIE INC. $18.16 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103957908 ABBVIE INC. $18.16 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103957910 ABBVIE INC. $15.77 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137582490 Takeda Pharmaceuticals U.S.A., Inc. $18.98 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137582494 Takeda Pharmaceuticals U.S.A., Inc. $19.45 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145085191 Mallinckrodt Hospital Products Inc. $16.00 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146124542 FUJIFILM Healthcare Americas Corporation $125.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146125854 FUJIFILM Healthcare Americas Corporation $125.00 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153426033 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.58 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153498119 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.12 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153510081 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.35 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153663390 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.16 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153664506 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.33 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153716660 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.87 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.